Side-by-side comparison
RHHVF vs ABT — Side-by-side comparison
ABT screens cheaper on EV/FCF, ABT has the higher ROIC, ABT has grown revenue faster over five years, and ABT has the cleaner balance sheet by net debt / EBITDA.
RHHVF
Roche Holdings AG DIV RT
Price
$425.05
Market cap
$263.8B
Day %
N/A
ABT
Abbott Labs
Price
$87.41
Market cap
$230.7B
Day %
N/A
Peer Comparison
Target stock against 1 market-cap comparable peer.
Heat map: red worst to green best
RHHVF implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
N/A
ABT implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
31.8x
FCF yield
3.2%
5Y rev CAGR
5.1%
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for RHHVF.
Grade F
0
/ 100
Quality Radar0 – 20 per axis
Quality Scorecard
Build-time composite score for ABT.
Grade C
64
/ 100
Quality Radar0 – 20 per axis